Navigation Links
Clinical Outsourcing Leaders Summit Set to Convene November 13
Date:10/2/2008

WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO) is pleased to announce it will convene the inaugural Clinical Outsourcing Leaders Summit with a select group of senior pharmaceutical, biotech and clinical research executives November 13, 2008 in Washington, DC.

This exclusive event will feature high-level, interactive discussions surrounding the impact of the presidential election on biomedical research and various aspects of drug development. Among the featured speakers are:

Dr. Mark B. McClellan, Senior Fellow and Director of The Engelberg Center for Healthcare Reform at the Brookings Institution and former commissioner of the Food and Drug Administration;

Bill Thomas, former U.S. Congressman and former Chairman of the House Committee on Ways and Means. Currently a Senior Advisor to Buchanan, Ingersoll & Rooney PC and a Visiting Fellow at the American Enterprise Institute;

Dr. Andrew Dahlem, Vice President and COO, Eli Lilly Laboratories;

Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research at the Food and Drug Administration;

Ken Getz, founder and chairman of the nonprofit CISCRP and a Senior Research Fellow at the Tufts Center for Drug Development, Tufts University Medical School;

Chris Singer, Executive Vice President and COO of PhRMA;

David Spaight, Chair of the ACRO Board of Directors and President of MDS Pharma Services;

Dr. Dennis Gillings, founding Chair of ACRO and Chairman and CEO of Quintiles Transnational Corp.

"Regardless of the outcome of the November elections, we know the drug development industry will face significant changes in the coming years," said ACRO Executive Director, Doug Peddicord, Ph.D. "This summit will bring together thought leaders from the biopharmaceutical and clinical outsourcing industries for an open dialogue on the political, economic and regulatory aspects of the changing healt
'/>"/>

SOURCE Association of Clinical Research Organizations
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Jefferson awarded multi-million dollar grant from National Eye Institute for new clinical trial
2. MultiVu Video Feed: NEW RESEARCH PUBLISHED IN THE AMERICAN JOURNAL OF CLINICAL NUTRITION FINDS PISTACHIOS IMPROVE RISK FACTORS FOR HEART DISEASE
3. What is the clinical features of primary aortoenteric fistula?
4. Medicare HMO costs may prevent cancer patient clinical trial participation
5. DIA Conference to Present Latest Strategies in Clinical Trial Disclosure Compliance
6. Novel tuberculosis vaccine in Germany in clinical phase
7. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
8. Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development
9. VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients
10. Shaping Best Practices For Standardized Medical Imaging In Clinical Trials
11. New probe to detect skin cancer receives more funding for clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Collins, CO (PRWEB) October 20, 2014 ... dGH assays are the only imaging assays capable ... in a single test.  With these three dimensions ... their ability to detect the widest range of ... translocations—mutations usually missed by other genomic tools, including ...
(Date:10/20/2014)... It’s hard to imagine what it’s like to live without ... world, it’s a reality. And while new shoes are considered ... walk barefoot on rocky terrain or sewage-lined streets just to ... , Buckner International's Shoes for Orphan Souls ... to encourage support for Air1 and while also providing new ...
(Date:10/19/2014)... Hastings and Hastings, a Phoenix personal injury law ... greater Phoenix area and across Arizona reports record demand ... automobile accidents. Statistics have indicated a steady increase in ... such, Hastings and Hastings has seen a steady increase ... have been injured through no fault of their own ...
(Date:10/19/2014)... 20, 2014 This report provides ... Seizure, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ... press releases. It also reviews key players involved ... special features on late-stage and discontinued projects. , ...
(Date:10/19/2014)... October 20, 2014 SweetDressy.com, a professional ... announced its promotion for long evening dresses . ... the special offer; the current discount is up to ... the industry pioneers in the fashion field. Its dress ... ladies dwelling in various parts of the world. All ...
Breaking Medicine News(10 mins):Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2
... News) -- Smoking boosts the risk of rheumatoid arthritis in ... risk factor for rheumatoid arthritis are among those most likely ... Researchers evaluated 605 black patients with rheumatoid arthritis and ... disease were slightly more likely to be former or current ...
... , MONDAY, Nov. 29 (HealthDay News) -- Genetics influence ... factors have the greatest impact in the summer, the results ... needed to maintain health and for strong bones, is naturally ... do not contain vitamin D unless it,s added by fortification. ...
... Neuroscientists at the Centre for Addiction and Mental Health (CAMH) ... type of highly targeted treatment for depression with a low ... time in their lives and is a leading cause of ... Nature Medicine found that coupling between two dopamine ...
... with GE Healthcare has produced the first results in humans ... presence and aggressiveness of prostate tumors in real time, by ... researchers have used this technology to conduct real-time metabolic imaging ... assessing the precise outlines of a tumor, its response to ...
... Mozes HealthDay Reporter , MONDAY, Nov. 29 (HealthDay ... tool is surging in emergency departments across the United States, ... to 2007, CT scan use in ERs increased by nearly ... concerns about the potential risks posed by more frequent exposure ...
... personal history of breast cancer should consider annual screening ... study presented today at the annual meeting of the ... Cancer Society (ACS) guidelines currently recommend annual screening with ... or with a strong family history indicating a lifetime ...
Cached Medicine News:Health News:Heavy Smoking May Double Rheumatoid Arthritis Risk in Blacks 2Health News:Neurological protein may hold the key to new treatments for depression 2Health News:New prostate cancer imaging shows real-time tumor metabolism 2Health News:New prostate cancer imaging shows real-time tumor metabolism 3Health News:New prostate cancer imaging shows real-time tumor metabolism 4Health News:CT Scan Use Surging in Hospital ERs 2Health News:CT Scan Use Surging in Hospital ERs 3Health News:CT Scan Use Surging in Hospital ERs 4Health News:Women with personal history of breast cancer should be screened with MRI 2
(Date:10/20/2014)... , 20 de octubre de 2014  PneumRx, ... campo de la pulmonología intervencional, anunció hoy la ... casi 3 meses antes de lo programado. El Estudio ... de dispositivo de investigación (IDE) aprobada por la ... sistema de espiral de reducción de volumen pulmonar ...
(Date:10/20/2014)... BRIDGEWATER, N.J. , Oct. 20, 2014 ... delivery technology designed for patients with Type 2 diabetes, ... Health Supply Chain Excellence Award. The award was presented ... Conference in Columbus, Ohio . ... recipients are judged across a variety of metrics specifically ...
(Date:10/20/2014)... Oct. 20, 2014 Lpath, Inc. (NASDAQ: ... bioactive lipid-targeted therapeutics, received official notification from the European ... another key patent supporting its iSONEP™ and ASONEP™ ... European patent No. 2087002, claims compositions of matter ... two lead compounds, iSONEP and ASONEP. Sonepcizumab is ...
Breaking Medicine Technology:PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4
Antiseptic - Antibacterial Sudsing Cleanser...
... This requiring no water for ... hand hygiene to physically clean ... is either not an option ... allows you to return to ...
BETASEPT® Scrub 4% is for surgical handscrubbing, healthcare personnel hand-washing, preoperative patient prepping and general skin degerming....
... Scrub Care® Brand soaps, emulsions, washes ... ultimate in healthy skin care, helping ... skin healthy and soft even with ... not contain petroleum-based substances that can ...
Medicine Products: